Platelet Activation by a Collagen Analogue in Hemorrhagic Situations
NCT ID: NCT04483245
Last Updated: 2023-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
83 participants
OBSERVATIONAL
2021-12-07
2023-04-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Recombinant Factor VIIa in Acute Intracerebral Haemorrhage
NCT00127283
Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage
NCT01566786
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
NCT01410227
Recombinant Factor VIIa in Acute Intracerebral Haemorrhage
NCT00426803
Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.
NCT01487837
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
controls
persons free of hemorrhage or haemostasis disorder
Blood sampling
Blood sampling
Haemorrhagic
Acute hemorrhagic patient
Blood sampling
Blood sampling
ECMO
ECMO surgery patient with hemorrhagic complication
Blood sampling
Blood sampling
polytrauma
Blood sampling
Blood sampling
Platelet disorder
Patient with an identified platelet disorder or treated with antiplatelet agents
Blood sampling
Blood sampling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sampling
Blood sampling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* adult
* Healthy volunteers or controls (patients seen in consultation, without history of hemmorhage, etc.).
or
* patients with acute bleeding: polytraumatized, or hemorrhage or intracerebral haemorrhage, or bleeding complications at the end surgery (in particular cardiac surgery with ECMO) or
* patients with antiplatelet therapy or
* patients with thrombocytopenia/thrombopathy
Exclusion Criteria
* person deprived of their liberty by judicial or administrative decision
* pregnant, parturient or breastfeeding woman
* person unable to express their non-opposition
* platelet transfusion on initial management
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DE MAISTRE 2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.